Description
BLOOD PRODUCTS AND SERVICES IDIQ
First action · last action
2019-10-01 · 2020-11-20
Transactions
2
First transaction's obligation
$337,447
Base + all options value (sum of deltas)
$218,653
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25617D0111
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$337,447= $337,447
- Mod P000012020-11-20-$118,794= $218,653
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$337,447 | $337,447 | BLOOD PRODUCTS AND SERVICES IDIQ |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2020-11-20 | −$118,794 | $218,653 | BLOOD PRODUCTS AND SERVICES IDIQ |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626N0555 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $654,692 | FY2026 |
| 36C25626P0618 | HANGER PROSTHETICS & ORTHOTICS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $15,119 | FY2026 |
| 36C25626N0492 | BAYER HEALTHCARE PHARMACEUTICALS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $386,860 | FY2026 |
| 36C25626N0469 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $396,000 | FY2026 |
| 36C25626N0461 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $271,226 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25620N0192_3600_VA25617D0111_3600 · retrieved 2026-09-26.